NEUROTOXICITY
Clinical trials for NEUROTOXICITY explained in plain language.
Never miss a new study
Get alerted when new NEUROTOXICITY trials appear
Sign up with your email to follow new studies for NEUROTOXICITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a simple arthritis drug tame CAR-T's brain risks?
Disease control CompletedThis study tested whether adding the drug anakinra to standard CAR-T cell therapy could reduce serious brain side effects in people with relapsed or refractory non-Hodgkin lymphoma. Fifteen participants received the combination. The goal was to see if anakinra could lower the rat…
Matched conditions: NEUROTOXICITY
Phase: PHASE2 • Sponsor: Marcela V. Maus, M.D.,Ph.D. • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Could a common ED drug shield cancer patients from chemo nerve pain?
Prevention CompletedThis study tested whether tadalafil, a drug often used for erectile dysfunction, can prevent nerve damage caused by docetaxel chemotherapy in men with metastatic prostate cancer. About 90 participants took either tadalafil every two days or standard care during their chemo. The g…
Matched conditions: NEUROTOXICITY
Phase: PHASE2 • Sponsor: Tri-Service General Hospital • Aim: Prevention
Last updated May 17, 2026 15:56 UTC